SHANGHAI., Sept. 18, 2020 – On Sept. 18, Ernst & Young and Fudan University School of Management hosted China’s Most Promising Company Award Ceremony 2020 in Shanghai. During the award ceremony, Keya Medical was recognized as the winner of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.

This year is the tenth anniversary of the Ernst and Young Fudan China’s Most Promising Company award. For the past ten years, the selection committee has recognized rising companies that demonstrate significant potential in becoming industry leaders. Companies are evaluated by the selection in a variety of categories including their capacity for sustained growth, their international development potential, and their demonstrated competitive advantage. This year, 37 emerging industry leaders were recognized at the event in industries such as healthcare, biotechnology, and aerospace.
The selection committee recognizes Keya Medical as a company that has the potential to continue striving for innovation in the years to come. Despite the challenges presented by the COVID-19 pandemic, Keya Medical remains in a position to develop new solutions that positively impact the market.

Since 2016, Keya Medical has been committed to using AI to develop software medical devices that enable healthcare delivery organizations to provide better patient care. Earlier this year, Keya Medical became the first medical imaging AI company in China to receive regulatory approval for a Class III AI medical device. DEEPVESSEL FFR, the only CT-FFR product approved for clinical use in China, uses deep learning technology to non-invasively perform a physiological functional assessment of the coronary arteries using coronary CT angiography scans. The company is continuing to develop products using deep learning that can be used in the diagnosis and treatment of patients with cardiovascular diseases.

Keya Medical is honored to be recognized as one of China’s Most Promising Companies. The company will continue developing products based on real clinical needs to improve care processes and treatment outcomes on a global scale.

About Keya Medical
Keya Medical Technology Co. Ltd. is a medical technology manufacturer that develops artificial intelligence applications that enable healthcare delivery organizations to provide better patient care. Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world. Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are used in Chinese hospitals, coronary catheterization labs, and imaging centers. To learn more about Keya Medical, follow us on LinkedIn and Twitter.